IDEX Biometrics ASA (IDBA)

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

IDEX Biometrics ASA held an extraordinary general meeting on 14 August 2025.All resolutions were passed as proposed in the notice and agenda update for the meeting.The minutes of the meeting will be available at the company's web site in due course.

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Reference is made to the announcement by IDEX Biometrics ASA on 21 July 2025. Regarding a private placement of 9,090,909 shares at NOK 3,30 per shares into two tranches.

IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Thursday 14 August 2025 at 12.00 am CEST as an online meeting. Shareholders may attend online by PC, smartphone or tablet. There is no physical attendance option. The EGM-notice with attendance form will be sent to the shareholders today and is also enclosed.

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders.

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

IDEX is executing well on the strategy announced in March 2025 and outlined in the Company's presentation held on 21 May 2025- IDEX-presentation-20250521.pdf. The Company's strategy is to become the world's leading biometric ID company, with a world class product portfolio in both ID & Access and Pay. IDEX has set out clear priorities, a disciplined capital allocation, and a sharp focus on building long-term value.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Reference is made to the notice on 11 April 2025 about the 100-to-1 share consolidation (reverse split) in IDEX Biometrics ASA, as resolved by the extraordinary general meeting held on the same day.

Issuer name:    IDEX Biometrics ASA Ex. date:    4 July 2025 Type of corporate action:    Share consolidation (reverse split) Previous ISIN:    NO0013107490 New ISIN:    NO0013536078 For further information contact: Anders Storbråten, CEO and CFOE-mail: anders@idexbiometrics.com About this notice This notice was published by Erling Svela, Vice president of finance, on 4 July 2025 at 08:00 CET on behalf of IDEX Biometrics ASA.

Reference is made to the following disclosures by IDEX Biometrics ASA: 15 June 2025: Issue of 299,381,600 new shares to employees, contractors and directors in IDEX.23 June 2025: Issue of 5,412,932 new shares in lieu of cash board remuneration as approved by the annual general meeting held on 21 May 2025.23 June 2025: Issue of 69 new shares to an employee to facilitate the 100-to-1 share consolidation as resolved by the extraordinary general meeting held on 11 April 2025. The share capital increases have been registered in the Norwegian Register of Business Enterprises.

Oslo, Norway, 27 June 2025  IDEX Biometrics ASA (“IDEX” or the “Company”) announces that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025.

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 23 June 2025 regarding the issuance of shares. IDEX Biometrics ASA informs of a primary insider transaction as listed in the attached notification.